Diagnosis and management of typical and atypical lung carcinoids

Sara Pusceddu, Giuseppe Lo Russo, Marianna Macerelli, Claudia Proto, Milena Vitali, Diego Signorelli, Monica Ganzinelli, Paolo Scanagatta, Leonardo Duranti, Annalisa Trama, Roberto Buzzoni, Giuseppe Pelosi, Ugo Pastorino, Filippo de Braud, Marina Chiara Garassino

Research output: Contribution to journalArticle

Abstract

An estimated 20% to 30% of all neuroendocrine tumours originate in the bronchial tree and lungs. According to the 2015 World Health Organization categorization, these tumours are separated into four subtypes characterized by increasing biological aggressiveness: typical carcinoid, atypical carcinoid, large-cell neuroendocrine carcinoma and small-cell carcinoma. Although typical and atypical lung carcinoids account for less than 1-5% of all pulmonary malignancies, the incidence of these neoplasms has risen significantly in recent decades. Surgery is the treatment of choice for loco-regional disease but for advanced lung carcinoids there is no recognized standard of care and successful management requires a multidisciplinary approach. The aim of this review is to provide a useful guide for the clinical management of lung carcinoids.

Original languageEnglish
Pages (from-to)167-176
Number of pages10
JournalCritical Reviews in Oncology/Hematology
Volume100
DOIs
Publication statusPublished - Apr 1 2016

Keywords

  • Atypical carcinoids
  • Lung carcinoids
  • Neuroendocrine tumours
  • Typical carcinoids

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Diagnosis and management of typical and atypical lung carcinoids'. Together they form a unique fingerprint.

  • Cite this